Plasma Claudin-5 Proteolytic Fragments Distinguish Paracellular BBB Breakdown from Transport Dysfunction
🧪 Overview
Claudin-5 is the most abundant tight junction protein in brain endothelial cells and is specifically degraded during early neurodegeneration. Proteolytic cleavage by MMPs and γ-secretase generates circulating C-terminal fragments detectable in plasma. Detection of these fragments specifically indicates paracellular BBB leakage, distinguishing it from transcytosis-mediated permeability changes. This hypothesis has therapeutic potential through tight junction stabilization, but requires de novo assay development and fragment identification before clinical validation can proceed.
🧬 Mechanism
Curated pathway from expert analysis
flowchart TD A["Neurodegeneration"] --> B["MMPs Activation"] A --> C["Gamma-Secretase Activation"] B --> D["Claudin-5 Cleavage"] C --> D D --> E["C-terminal Fragments"] E --> F["Plasma Detection"] F --> G["Paracellular BBB Breakdown"] G --> H["Cognitive Decline"] G --> I["Neuroinflammation"] A --> J["Transcytosis Upregulation"] J --> K["Transport Dysfunction"] K --> H K --> I F -->|" Distinguishes "|K L["Minocycline or PPAR-gamma Agonists"] --> M["Tight Junction Stabilization"] M --> N["Claudin-5 Protection"] N --> D N -->|" Prevents "|O["BBB Leakage Reduction"]
⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — CLDN5
No curated PDB or AlphaFold mapping for CLDN5 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for CLDN5 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for CLDN5.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If plasma claudin-5 proteolytic fragments specifically distinguish paracellular BBB breakdown from transcytosis, then fragment patterns will differ between paracellular leakage (high full-length CLDN5 | In patients with confirmed BBB dysfunction (n≥80), western blot analysis shows two distinct fragment patterns: Pattern A (paracellular: full-length CLDN5 + N-te | — no observation — | pending | 0.77 |
| If CLDN5 fragment elevation specifically reflects paracellular BBB disruption, then plasma CLDN5 fragments will be absent or low in pure transcytosis models (e.g., diabetic patients without BBB imagin | In pure transcytosis model (type 2 DM without MRI BBB changes, n≥30), plasma CLDN5 fragments are within normal range (<100 pg/mL); in paracellular disruption (T | — no observation — | pending | 0.72 |
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |